This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 05 Feb 2021  |  North America  |  Mega Trends

    Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

    Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

    The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

    $4,950.00
  2. 03 Feb 2021  |  North America  |  Mega Trends

    Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

    Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

    2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

    $4,950.00
  3. 03 Sep 2019  |  North America  |  Market Research

    Global Single Cell Genomics and Proteomics Market, Forecast to 2023

    Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place

    Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. Th...

    $1,500.00
  4. 29 Dec 2015  |  Global  |  Technology Research

    Collaboration between Medical Devices, Pharmaceuticals, and Biotechnology

    Strategic Partnerships that are Transforming the Healthcare Industry

    In an increasingly convergent industry such as healthcare, business collaborations are not only a necessity, but an inevitability. It is interesting to note that technologies and market segments that receive the most funding and research focus, are also the areas that are ripe for collaborative partnerships. Market segments such as personalized med...

    $4,950.00
  5. 24 Dec 2015  |  North America  |  Market Research

    Global Clinical Next-generation Sequencing Market

    Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

    This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tab...

    $1,500.00
  6. 24 Dec 2015  |  Europe  |  Market Research

    Analysis of the Western European Clinical Laboratories Market

    Public Hospital Service Outsourcing to Drive the Growth of Independent Reference Labs

    Laboratory consolidations and outsourcing of services are providing more opportunities to the clinical labs. How the market is going to shape up and how the laboratory services structure is transforming in Western Europe is analyzed in this research service. The study provides market overview, market engineering measurements and revenue forecasts, ...

    $6,000.00
  7. 22 Dec 2015  |  Europe  |  Market Research

    Healthcare Services Market Outlook for Eastern Europe

    Country-level Analysis of Healthcare Systems and Private Hospital Markets

    This research service provides an overview of the healthcare systems of selected countries and a competitive analysis of their private hospital markets. The study includes data and analyses on each countrys economic, demographic, and epidemic conditions, the healthcare system and reforms, healthcare expenditure and fund flow system, healthcare infr...

    $4,950.00
  8. This issue profiles cancer cell imaging technologies.

    $950.00
  9. 15 Dec 2015  |  Asia Pacific  |  Market Research

    Analysis of the Medical Imaging Market in Selected ASEAN Countries

    Growth and Trends in CT, MR, PET, and SPECT Modalities

    This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

    $6,000.00
  10. This issue profiles technology advances and trends for the treatment of sleep apnea.

    $750.00